Both in Pharmaceuticals
Rafael Holdings vs Xilio Therapeutics
Over the past year RFL returned −19.5% and XLO returned −22.4%; their daily moves had a correlation of -0.11.
RFL −19.5% XLO −22.4%Growth of $1, one year, split-adjusted
| Metric | RFL | XLO |
|---|---|---|
| Price | $1.07 | $8.71 |
| Market cap | $55.8M | $57.3M |
| Today | −0.93% | +0.35% |
| 1 month | −28.2% | −3.2% |
| 6 months | −14.4% | +10.3% |
| Year to date | −9.3% | −2.8% |
| 1 year | −20.7% | −26.8% |
| Revenue growth (YoY) | −30.3% | +131.2% |
| Gross margin | 94.7% | 100.0% |
| Net margin | −3760.7% | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | 63.9× | 0.9× |
| Net cash | $21.5M | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | 115.0% | 38.3% |
| Short % of float | 1.0% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).